IXHLIncannex Healthcare Inc.
Earnings
When Incannex Healthcare Inc. reports, what it reported each quarter, and how the stock took the results.
14 quarters. Mar 31, 2023 to Sep 30, 2026. USD.
Next results · Q2 2027Projected
10-Q due Feb 10 – 17
No earnings release is on file for this company, so the day is the 10-Q’s, projected from its last 8 filings.
- Quarter
- Q2 2027 · Ends about Dec 31, 2026
- 10-Q window
- Feb 10 – 17
Read against Q2 2026
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- —
- Revenue, change from a year earlier: Q1 2027 n/m, Q1 2026 −100.0%, Q4 2025 n/m, Q3 2025 n/m
- Net income
- -$6.52M
- Net income, change from a year earlier: Q1 2027 n/m, Q4 2026 n/m, Q3 2026 n/m, Q2 2026 n/m
- EPS
- -$0.02
- EPS, change from a year earlier: Q1 2027 n/m, Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m
Latest results
- Revenue
- $0.00
- —
- Net income
- -$1.94M
- N/M
- EPS
- -$0.15
- N/M
- Revenue
- —
- —
- Net income
- -$2.49M
- N/M
- EPS
- —
- —
- Revenue
- —
- —
- Net income
- -$3.88M
- N/M
- EPS
- -$0.35
- N/M
- Revenue
- —
- —
- Net income
- -$6.52M
- N/M
- EPS
- -$0.02
- N/M
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2027 | ||||||||||
| Q1 2027 | Sep 30, 2026 | — | Nov 12, 2026 | 43 d | 10-Q | $0.00 | — | -$0.15 | +3.0% | |
| FY 2026 | ||||||||||
| Q4 2026derived | Jun 30, 2026 | — | Sep 25, 2026 | 87 d | 10-K | — | — | — | 2.6% | |
| Q3 2026 | Mar 31, 2026 | — | May 15, 2026 | 45 d | 10-Q | — | — | -$0.35 | +2.1% | |
| Q2 2026 | Dec 31, 2025 | — | Feb 13, 2026 | 44 d | 10-Q | — | — | -$0.02 | 0.7% | |
| Q1 2026 | Sep 30, 2025 | — | Nov 14, 2025 | 45 d | 10-Q | $0.00 | −100.0% | -$0.62 | 2.8% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Jun 30, 2025 | — | Sep 29, 2025 | 91 d | 10-K | $0.00 | — | — | 11.9% | |
| Q3 2025 | Mar 31, 2025 | — | May 15, 2025 | 45 d | 10-Q | $0.00 | — | -$6.19 | 61.4% | |
| Q2 2025 | Dec 31, 2024 | — | Feb 14, 2025 | 45 d | 10-Q | $12.00K | — | -$0.33 | 1.1% | |
| Q1 2025 | Sep 30, 2024 | — | Nov 14, 2024 | 45 d | 10-Q | $74.00K | — | -$0.29 | 14.5% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Jun 30, 2024 | — | Sep 30, 2024 | 92 d | 10-K | — | — | — | 1.5% | |
| Q3 2024 | Mar 31, 2024 | — | May 15, 2024 | 45 d | 10-Q | — | — | -$0.38 | +10.7% | |
| Q2 2024 | Dec 31, 2023 | — | Feb 14, 2024 | 45 d | 10-Q | — | — | -$0.33 | +11.8% | |
| Q1 2024 | Sep 30, 2023 | — | — | — | — | — | — | -$0.08 | — | |
| FY 2023 | ||||||||||
| Q3 2023 | Mar 31, 2023 | — | — | — | — | — | — | -$0.22 | — | |
Earlier years, FY 2023 to FY 2024The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Incannex Healthcare Inc. · CIK 1873875 · Engraved from SEC EDGAR